Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 11 | 0 | 0 | 0 |
| Receivables | 10 | 0 | 0 | 0 |
| Inventories | 6 | 0 | 0 | 0 |
| TOTAL | $27 | $0 | $0 | $0 |
| Non-Current Assets | ||||
| PPE Net | 25 | N/A | N/A | N/A |
| TOTAL | $25 | $N/A | $N/A | $N/A |
| Total Assets | $52 | $0 | $0 | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 231 | 0 | 0 | 0 |
| Accrued Expenses | 27 | 0 | 0 | 0 |
| Other current liabilities | 5 | 0 | 0 | 0 |
| TOTAL | $342 | $0 | $0 | $0 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $342 | $0 | $0 | $0 |
| Shareholders' Equity | ||||
| Common Shares | 28 | 0 | 0 | 0 |
| Retained earnings | -13,883 | 0 | 0 | 0 |
| TOTAL | $-291 | $0 | $0 | $0 |
| Total Liabilities And Equity | $52 | $0 | $0 | $0 |